Gold tier: mechanically validated evidence, with its primary source.
2,235 evidence items · page 40 / 90
96.6 %For cellular viral DNA, useful PR and RT sequences were obtained for 96.6% and 93.1% of the whole-blood-cell samples and for 93.1% and 93.1% of the DBS samples, respectively.
KenyaVIH/sidapublished 2007Journal of clinical microbiologyeurope_pmcdocument of 4 observations
13.3 %The mean proportion of follow-up covered by biomedical HIV prevention was 13.3% in the standard-of-care group.
KenyaVIH/sidapublished 2024The lancet. HIVPubMeddocument of 9 observations
34 %Among caregivers with untested children ≤12 years, 34% (166/483) of males and 89% (320/358) of females were eligible for index case testing for HIV.
KenyaVIH/sidapublished 2021Journal of acquired immune deficiency syndromes (1999)PubMeddocument of 3 observations
72 %Missed opportunities for PrEP initiation were 72% among female sex workers (FSW).
KenyaVIH/sidaobserved February 2017 to December 2019published 2020Journal of the International AIDS SocietyPubMeddocument of 13 observations
14 %Other infections were present in 22 (14%) of 162 HIV-attributed infant or child deaths.
Kenyaother infections · VIH/sidaobserved Dec 3, 2016 to Dec 31, 2024published 2026The lancet. HIVPubMeddocument of 23 observations
Among adolescent girls in Kenya, sexual violence from intimate partners decreased between 2016/2017 and 2018.
KenyaVIH/sidaobserved 2016/2017, 2018published 2022BMJ openPubMeddocument of 18 observations
The 3TC mutation M184V and the NNRTI mutation K103N were the most frequent resistance mutations observed.
KenyaVIH/sidapublished 2009AIDS research and therapyeurope_pmcdocument of 8 observations
1,300,000 inhabitantsThere were 1.3 million people living with HIV in Kenya.
KenyaVIH/sidapublished 2025BMC public healthPubMeddocument of 12 observations
61.2 %Among 651 (97.0%) participants who had ever been tested for HIV, 400 (61.2%) reported HIV testing in the past 6 months.
KenyaVIH/sidapublished 2021BMC public healthPubMeddocument of 8 observations
7 infectionsThere were seven incident HIV infections in 390 person-years of follow-up in the standard-of-care group.
KenyaVIH/sidapublished 2024The lancet. HIVPubMeddocument of 9 observations
1,700,000 individualsThere are approximately 1.7 million adolescents living with HIV globally.
KenyaVIH/sidapublished 2021Journal of the International AIDS SocietyPubMeddocument of 4 observations
12 %Of the male partners tested, 524 (12%) were newly diagnosed with HIV.
KenyaVIH/sidaobserved May 1, 2018 to March 31, 2020published 2023The Lancet. Global healthPubMeddocument of 11 observations
6 %Mean predicted risk probability among pregnant and postpartum women with HIV with known HIV diagnosis was 6% in the low-risk quintile.
KenyaVIH/sidapublished 2025AIDS and behaviorPubMeddocument of 13 observations
18 US$The mean total unit cost of antiretroviral therapy (ART) was US$18 in Kenya.
KenyaVIH/sidaobserved 2019published 2023BMC health services researchPubMeddocument of 11 observations
50 copies_per_mLIn the BREATHER Plus trial, participants had an HIV-1 viral load of less than 50 copies per mL over the previous 12 months.
KenyaVIH/sidaobserved previous 12 monthspublished 2026The lancet. HIVPubMeddocument of 10 observations
97.9 %In the APS+HIVST arm, 97.9% (2111/2157) of eligible partners were tested for HIV.
KenyaVIH/sidaobserved 2021published 2024Journal of the International AIDS SocietyPubMeddocument of 15 observations
HIV vaccines studied in these trials had a low potential of induction of persisting HIV antibodies.
KenyaVIH/sidaobserved 2001-2007published 2014Human vaccines & immunotherapeuticseurope_pmcdocument of 10 observationsDOI 10.4161/hv.27559
54 %Among children with HIV who underwent genotypic drug resistance testing in Kisumu County, Kenya, 54% had dual-class resistance.
KenyaVIH/sidaobserved March 2019 to December 2020published 2023VirusesPubMeddocument of 8 observations
1.41 odds_ratioThe odds ratio for detection of vaginal HIV-1 RNA before versus during Trichomonas vaginalis infection was 1.41 (95% CI 0.23–8.79, p = 0.7).
KenyaVIH/sidapublished 2011BMC infectious diseaseseurope_pmcdocument of 5 observations
62,000 childrenAn estimated 62,000 children aged 0–14 years are living with HIV in Kenya.
KenyaVIH/sidaobserved 2024published 2025AIDS research and therapyPubMeddocument of 6 observations
78 %78% of the adolescents and young adults living with HIV reported that disclosure positively influenced their antiretroviral therapy (ART) adherence.
KenyaVIH/sidaobserved 2019published 2023Frontiers in public healthPubMeddocument of 18 observations
12.68 %Providing PrEP for all uninfected individuals identified through TMP averted up to 12.68% of new infections.
KenyaVIH/sidapublished 2023EpidemicsPubMeddocument of 7 observations
38.5 %Attrition at 12 months after enrollment among people living with HIV regardless of antiretroviral therapy status was 38.5% (95% CI 38.4–38.6).
KenyaVIH/sidapublished 2020PloS onePubMeddocument of 12 observations
29 %Among smear-positive pulmonary tuberculosis/HIV co-infected patients in Kenya between 2012 and 2015, 29% of women and 20% of men had HIV testing more than 3 months prior to TB treatment.
Kenyatuberculose · VIH/sidaobserved 2012-2015published 2020PloS onePubMeddocument of 6 observations
97 %Of primary partners who were offered an HIV self-test, 97% accepted it.
KenyaVIH/sidapublished 2020Journal of the International AIDS SocietyPubMeddocument of 15 observations
Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.